130 related articles for article (PubMed ID: 38143961)
1. Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling.
Zalivina I; Barwari T; Yin X; Langley SR; Barallobre-Barreiro J; Wakimoto H; Zampetaki A; Mayr M; Avkiran M; Eminaga S
J Mol Cell Cardiol Plus; 2023 Dec; 6():100056. PubMed ID: 38143961
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
[TBL] [Abstract][Full Text] [Related]
3. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
4. [MicroRNA-199a-3p enhances expressions of fibrosis-associated genes through targeting Smad1 in mouse cardiac fibroblasts].
Liang J; Zhu W; Zhang Z; Zhu J; Fu Y; Lin Q; Kuang S; Zhang M; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1203-1208. PubMed ID: 30377137
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-Regulated Pathways for Hypertrophic Cardiomyopathy: Network-Based Approach to Insight into Pathogenesis.
Osmak G; Baulina N; Kiselev I; Favorova O
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946964
[TBL] [Abstract][Full Text] [Related]
6. Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis.
Zeng N; Huang YQ; Yan YM; Hu ZQ; Zhang Z; Feng JX; Guo JS; Zhu JN; Fu YH; Wang XP; Zhang MZ; Duan JZ; Zheng XL; Xu JD; Shan ZX
Mol Ther Nucleic Acids; 2021 Dec; 26():1035-1050. PubMed ID: 34786209
[TBL] [Abstract][Full Text] [Related]
7. miR-199a-3p promotes cardiomyocyte proliferation by inhibiting Cd151 expression.
Tao Y; Zhang H; Huang S; Pei L; Feng M; Zhao X; Ouyang Z; Yao S; Jiang R; Wei K
Biochem Biophys Res Commun; 2019 Aug; 516(1):28-36. PubMed ID: 31186138
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix-derived extracellular vesicles promote cardiomyocyte growth and electrical activity in engineered cardiac atria.
An M; Kwon K; Park J; Ryu DR; Shin JA; Lee Kang J; Choi JH; Park EM; Lee KE; Woo M; Kim M
Biomaterials; 2017 Nov; 146():49-59. PubMed ID: 28898757
[TBL] [Abstract][Full Text] [Related]
9. Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy.
Liu Y; Afzal J; Vakrou S; Greenland GV; Talbot CC; Hebl VB; Guan Y; Karmali R; Tardiff JC; Leinwand LA; Olgin JE; Das S; Fukunaga R; Abraham MR
Front Cardiovasc Med; 2019; 6():170. PubMed ID: 31921893
[No Abstract] [Full Text] [Related]
10. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
[TBL] [Abstract][Full Text] [Related]
11. ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.
Feyen E; Ricke-Hoch M; Van Fraeyenhove J; Vermeulen Z; Scherr M; Dugaucquier L; Viereck J; Bruyns T; Thum T; Segers VFM; Hilfiker-Kleiner D; De Keulenaer GW
Circ Heart Fail; 2021 Jul; 14(7):e006898. PubMed ID: 34247489
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium.
Joris V; Gomez EL; Menchi L; Lobysheva I; Di Mauro V; Esfahani H; Condorelli G; Balligand JL; Catalucci D; Dessy C
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2345-2357. PubMed ID: 29976767
[TBL] [Abstract][Full Text] [Related]
13. A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy.
Thottakara T; Lund N; Krämer E; Kirchhof P; Carrier L; Patten M
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827715
[TBL] [Abstract][Full Text] [Related]
14. Circulating Levels of MicroRNAs in Hypertrophic Cardiomyopathy: The Relationship With Left Ventricular Hypertrophy, Left Atrial Dilatation and Ventricular Depolarisation-Repolarisation Parameters.
Sonsöz MR; Yilmaz M; Cevik E; Orta H; Bilge AK; Elitok A; Onur I; Komurcu-Bayrak E
Heart Lung Circ; 2022 Feb; 31(2):199-206. PubMed ID: 34088630
[TBL] [Abstract][Full Text] [Related]
15. Exploration and validation of downregulated microRNA-199a-3p, downstream messenger RNA targets and transcriptional regulation in osteosarcoma.
Huang WT; Liu AG; Cai KT; He RQ; Li Z; Wei QJ; Chen MY; Huang JY; Yan WY; Zhou H; Chen G; Ma J
Am J Transl Res; 2019; 11(12):7538-7554. PubMed ID: 31934299
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory, Anti-fibrotic and Pro-cardiomyogenic Effects of Genetically Engineered Extracellular Vesicles Enriched in miR-1 and miR-199a on Human Cardiac Fibroblasts.
Kmiotek-Wasylewska K; Bobis-Wozowicz S; Karnas E; Orpel M; Woźnicka O; Madeja Z; Dawn B; Zuba-Surma EK
Stem Cell Rev Rep; 2023 Nov; 19(8):2756-2773. PubMed ID: 37700183
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
[TBL] [Abstract][Full Text] [Related]
18. Small RNA and transcriptome sequencing reveal the role of miR-199a-3p in inflammatory processes in cystic fibrosis airways.
Bardin P; Marchal-Duval E; Sonneville F; Blouquit-Laye S; Rousselet N; Le Rouzic P; Corvol H; Tabary O
J Pathol; 2018 Aug; 245(4):410-420. PubMed ID: 29732561
[TBL] [Abstract][Full Text] [Related]
19. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway.
Yang X; Ma L; Wei R; Ye T; Zhou J; Wen M; Men R; Aqeilan RI; Peng Y; Yang L
Signal Transduct Target Ther; 2020 Jun; 5(1):75. PubMed ID: 32499481
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.
Park KM; Teoh JP; Wang Y; Broskova Z; Bayoumi AS; Tang Y; Su H; Weintraub NL; Kim IM
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H371-83. PubMed ID: 27288437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
